landiolol
landiolol is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including RAPIBLYK. Available dosage form: injection, powder, lyophilized, for solution.
Drug Details
- Generic Name
- landiolol
- Brand Names
- RAPIBLYK
- Application Number
- NDA217202
- Sponsor
- AOP Orphan Pharmaceuticals GmbH
- NDC Codes
- 1
- Dosage Forms
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Routes
- INTRAVENOUS
- Active Ingredients
- LANDIOLOL HYDROCHLORIDE
Indications and Usage
1 INDICATIONS AND USAGE RAPIBLYK is indicated for the short-term reduction of ventricular rate in adults with supraventricular tachycardia including atrial fibrillation and atrial flutter, and pediatric patients with supraventricular tachycardia. RAPIBLYK is a beta adrenergic blocker indicated for the short-term reduction of ventricular rate in: adults with supraventricular tachycardia including atrial fibrillation and atrial flutter ( 1 ), and pediatric patients with supraventricular tachycardia.( 1 )